Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.9M Sell
100,135
-1,382
-1% -$162K 0.22% 97
2026
Q1
$12.2M Sell
101,517
-1,269
-1% -$147K 0.41% 49
2025
Q4
$9.59M Sell
102,786
-16,943
-14% -$1.59M 0.23% 90
2025
Q3
$10M Sell
119,729
-314
-0.3% -$25.9K 0.19% 102
2025
Q2
$9.5M Buy
120,043
+26,643
+29% +$2.12M 0.2% 107
2025
Q1
$8.38M Buy
93,400
+34,628
+59% +$3.23M 0.26% 72
2024
Q4
$5.85M Sell
58,772
-1,944
-3% -$200K 0.24% 92
2024
Q3
$6.89M Buy
60,716
+2,955
+5% +$351K 0.29% 68
2024
Q2
$7.15M Buy
57,761
+5,508
+11% +$709K 0.34% 56
2024
Q1
$6.89M Buy
52,253
+748
+1% +$92.2K 0.35% 59
2023
Q4
$5.62M Buy
51,505
+8,241
+19% +$855K 0.33% 68
2023
Q3
$4.45M Buy
43,264
+339
+0.8% +$36.5K 0.33% 69
2023
Q2
$4.95M Sell
42,925
-2,888
-6% -$328K 0.35% 60
2023
Q1
$4.87M Buy
45,813
+257
+0.6% +$27.7K 0.35% 64
2022
Q4
$5.05M Sell
45,556
-1,495
-3% -$153K 0.39% 60
2022
Q3
$4.05M Sell
47,051
-1,014
-2% -$90.5K 0.34% 66
2022
Q2
$4.38M Buy
48,065
+880
+2% +$78K 0.35% 61
2022
Q1
$3.87M Sell
47,185
-5,819
-11% -$459K 0.26% 91
2021
Q4
$4.06M Buy
53,004
+5,232
+11% +$417K 0.26% 85
2021
Q3
$3.59M Buy
47,772
+2,092
+5% +$159K 0.26% 64
2021
Q2
$3.55M Buy
45,680
+4,381
+11% +$326K 0.28% 88
2021
Q1
$3.04M Buy
41,299
+620
+2% +$45.7K 0.29% 79
2020
Q4
$3.17M Sell
40,679
-28,560
-41% -$2.18M 0.33% 67
2020
Q3
$5.48M Buy
69,239
+36,089
+109% +$2.83M 0.42% 49
2020
Q2
$2.45M Buy
33,150
+29,126
+724% +$2.19M 0.37% 74
2020
Q1
$295K Sell
4,024
-30,831
-88% -$2.42M 0.57% 53
2019
Q4
$3.02M Buy
+34,855
New +$2.86M 0.38% 61

Other funds holding MRK

J.W. Cole Advisors's MRK Position: Q2 2026 in Review

J.W. Cole Advisors reduced its Merck (MRK) stake by 1.4% in Q2 2026, selling an estimated $162K and leaving 100,135 shares worth $12.9M. The position accounts for 0.22% of the portfolio, ranked #97.

J.W. Cole Advisors first reported a position in MRK in Q4 2019 and has held it in 27 quarters since. 1,299 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • J.W. Cole Advisors held 100,135 shares of Merck worth $12.9M as of Q2 2026.
  • J.W. Cole Advisors sold 1,382 Merck shares in Q2 2026, an estimated $162K.
  • Merck made up 0.22% of J.W. Cole Advisors's portfolio in Q2 2026, its #97 holding.
  • J.W. Cole Advisors first reported a position in Merck in Q4 2019 and has held it in 27 quarters since.
  • 1,299 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.